INSIGHTS

Insights that cut through complexity

Pharmacogenetics and Pharmacogenomics: The Future of Precision Medicine

Pharmacogenetics and Pharmacogenomics: The Future of Precision Medicine

Over the past five years, Sally struggled with depression, and despite trying various treatments, none seemed to benefit her. Recently,…
Webinar On-Demand: Breaking Down the Hottest Topic in Pharmacy: Humira Biosimilars

Webinar On-Demand: Breaking Down the Hottest Topic in Pharmacy: Humira Biosimilars

Uncover what could happen with Humira and the biosimilar market in 2023  While biosimilars have existed for many years, the…
Potent Veterinary Drug Resistant to Narcan and It's Rising Illicit Use Among Humans - RemedyOne's Rob Louie Quoted in an Insightful Analysis with Fox News

Potent Veterinary Drug Resistant to Narcan and It's Rising Illicit Use Among Humans - RemedyOne's Rob Louie Quoted in an Insightful Analysis with Fox News

A Fox News article recently quoted RemedyOne EVP of clinical services Rob Louie on xylazine, a potent veterinary drug that…
Hemophilia Gene Therapies: Are the World’s Most Expensive Drugs Really Worth It?

Hemophilia Gene Therapies: Are the World’s Most Expensive Drugs Really Worth It?

Hemgenix became the most expensive drug in the history of FDA-approvals back in November of 2022 after the manufacturer, CSL…
What Is a Cough Medicine Doing in My Anti-depressant?

What Is a Cough Medicine Doing in My Anti-depressant?

This might come as a surprise to some individuals as they dive into the listed ingredients of the newest FDA-approved…
Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars

Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars

The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch…
Unpacking the Biosimilar Buzz

Unpacking the Biosimilar Buzz

As industry experts, it’s the number one topic we’re being asked to comment on. While biosimilars have existed for many…
Study Shows Talarozole May Help Osteoarthritis Patients

Study Shows Talarozole May Help Osteoarthritis Patients

Healthline recently asked me to provide context for an article about recent research showing that talarozole may reduce and modify…
Competition is on the Horizon for Costly Narcolepsy Treatments

Competition is on the Horizon for Costly Narcolepsy Treatments

See this article by RemedyOne clinical pharmacist, Jason Peterson, R.Ph. as it originally appeared in Pharmaphorum.  People who live with narcolepsy —…
It’s Been a Long Time Coming for Long-Term Topical Psoriasis Treatments

It’s Been a Long Time Coming for Long-Term Topical Psoriasis Treatments

RemedyOne EVP of clinical services Robert Louie recently published an article for Pharmaphorum about topical psoriasis treatments Vtama and Zoryve.…
Relyvrio and the ALS Treatment Landscape

Relyvrio and the ALS Treatment Landscape

Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s Disease, is a rare, progressive, neurodegenerative disorder that affects nerve…
Enhertu: The New Oncology ‘Smart Bomb’

Enhertu: The New Oncology ‘Smart Bomb’

An article on Health.com recently quoted me about an exciting new FDA-approved drug shown to extend metastatic breast cancer patients’…
Monkeypox

Monkeypox

Recent months have brought new waves of viral infections across the globe, particularly, monkeypox. Scientists first identified monkeypox in Denmark…
Mounjaro: Competing To Be the Best

Mounjaro: Competing To Be the Best

Jason Peterson and RemedyOne EVP of clinical services Robert Louie have also written about Mounjaro for Pharmaphorum.  Man o’ War,…
Drug Treatment of Presbyopia: Medical Necessity or Convenience?

Drug Treatment of Presbyopia: Medical Necessity or Convenience?

Some say things get better with age. Cheese, wine, and whiskey are a few examples that come to mind. Unfortunately,…
Six Months After Authorization, What Do We Know About Paxlovid?

Six Months After Authorization, What Do We Know About Paxlovid?

See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum.  It has now…
How the Pharmaceutical Industry Can Turn the Tide on Mental Health

How the Pharmaceutical Industry Can Turn the Tide on Mental Health

May is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical…
New Developments in Macular Degeneration/Diabetic Eye Disease

New Developments in Macular Degeneration/Diabetic Eye Disease

Visual impairment can be a major health issue for older adults, ranging from a minor inconvenience to vision loss significantly…
Drug Innovation Continues Despite a World-Wide Pandemic

Drug Innovation Continues Despite a World-Wide Pandemic

While much of the world was on pause during the COVID-19 pandemic, there are definite signs that even a pandemic…
Three Pharmacy Trends That Will Define 2022

Three Pharmacy Trends That Will Define 2022

See article as it originally appeared in MedCity News.  The pharmaceutical industry made more headlines in 2021 than in any…
2022 Q1 RemedyOne Quarterly Pipeline Report

2022 Q1 RemedyOne Quarterly Pipeline Report

Download our 2022 Q1  Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
High Cost, Lifelong Treatments and the Impact on Payers and Patients

High Cost, Lifelong Treatments and the Impact on Payers and Patients

Healthcare payers may not be familiar with the high costs of paroxysmal nocturnal hemoglobinuria (PNH), or even know what it…
Want the Lowest-Net-Cost Drugs? Change Your Thinking on Disruption

Want the Lowest-Net-Cost Drugs? Change Your Thinking on Disruption

It might seem like a lowest-net-cost formulary would be made up of clinically equivalent agents with the lowest overall cost.…
COVID-19 Treatment Developments

COVID-19 Treatment Developments

Introduction Recent data from Johns Hopkins University showed over 760,000 people in the U.S. have died from the coronavirus to…
Q3 2021 Drug Pipeline Recap

Q3 2021 Drug Pipeline Recap

The Latest Developments in Drug Approvals Each quarter, the RemedyOne Clinical team curates a drug pipeline report for our clients…
2021 Q4 RemedyOne Quarterly Pipeline Report

2021 Q4 RemedyOne Quarterly Pipeline Report

Download our 2021 Q4  Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
No One Really Knows How We’ll Pay for Gene Therapies

No One Really Knows How We’ll Pay for Gene Therapies

Gene therapies are here and they have the potential to be miraculous. And extremely expensive. The science behind these therapies…
COVID-19 Treatment Update

COVID-19 Treatment Update

The last year and a half brought many rapid changes and innovations across the globe and in no area more than healthcare. From finding the most effective treatments to developing tests and…
The Implications of Polypharmacy on the Payor and Patient

The Implications of Polypharmacy on the Payor and Patient

There is a delicate balance between prescribing new medications and identifying and eliminating unnecessary prescriptions to protect the overall care…
2021 Q3 RemedyOne Quarterly Pipeline Report

2021 Q3 RemedyOne Quarterly Pipeline Report

Download our 2021 Q3  Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
Biogen’s New Alzheimer’s Drug is a Compound of Hope and Controversy

Biogen’s New Alzheimer’s Drug is a Compound of Hope and Controversy

For the first time in 18 years, the FDA has approved a drug to treat patients with Alzheimer’s disease. It’s…
Can the Vaccine Rollout Guide Us to More Efficient Health Care?

Can the Vaccine Rollout Guide Us to More Efficient Health Care?

What the Covid vaccine taught us, and how we can be better. See this article as it originally appeared in…
Effects of COVID-19 on Mental Health

Effects of COVID-19 on Mental Health

As the number of COVID-19 hospitalizations and deaths are trending downward and vaccines are currently showing efficacy in the U.S.,…
Hospital Price Transparency Rule Not Enough to Lower Drug Prices

Hospital Price Transparency Rule Not Enough to Lower Drug Prices

Our healthcare system is extremely complex and increasing drug pricing transparency will be a big part of simplifying it in…
2021 Q2 RemedyOne Quarterly Pipeline Report

2021 Q2 RemedyOne Quarterly Pipeline Report

Download our 2021 Q2  Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
Digital Health Trends: Digital Therapeutics

Digital Health Trends: Digital Therapeutics

Defining the Digital Health Landscape Digital health has been a trending topic for several years now. Using technology to improve…
The Latest on HIV Treatment

The Latest on HIV Treatment

History HIV treatment has come a long way since 1987 when the first breakthrough zidovudine, a failed cancer drug from…
The Most Favored Nation Model and Interim Final Rule – What is this?

The Most Favored Nation Model and Interim Final Rule – What is this?

The rising costs of physician-administered drugs covered under Medicare Part B is one of the largest drivers of Medicare spend…
“Alexa, Refill My Prescription!”

“Alexa, Refill My Prescription!”

Introducing: Amazon Pharmacy….. What this launch means for the $300 billion prescription drug market and the traditional pharmacy chains currently…
Don’t Let the Fox Guard Your Henhouse: 6 Questions to Ask Your Large National Broker

Don’t Let the Fox Guard Your Henhouse: 6 Questions to Ask Your Large National Broker

Pharmacy benefits are complex, seemingly on purpose. If you are with a large national broker and are utilizing their coalition…
COVID-19 Vaccine Update

COVID-19 Vaccine Update

COVID-19 has infected over 10 million people in the United States and has claimed the lives of over 237,000 people…
Cutting Through the Complexity of Biosimilars

Cutting Through the Complexity of Biosimilars

The biologic drug market is huge in the US and it continues to grow at a rapid pace. However, great…
Uncovering Solutions for Affordable Drug Pricing

Uncovering Solutions for Affordable Drug Pricing

The House Committee on Oversight and Reform held a series of hearings to review findings from an in-depth investigation into…
RemedyOne Drug Spotlight: Rukobia

RemedyOne Drug Spotlight: Rukobia

Rukobia (fostemasavir) There are an estimated 2 million people living with the human immunodeficiency virus (HIV) in the United States.…
CMS’s Proposed Prescription Drug Value-Based Purchasing Rule

CMS’s Proposed Prescription Drug Value-Based Purchasing Rule

Paving the Way for Payment Innovation On June 17, 2020, CMS announced a proposed rule that would change how pharmaceutical manufacturers…
Arbuterol 101 Plus...

Arbuterol 101 Plus...

Albuterol is a short acting beta agonist (SABA) used to treat or prevent bronchospasm in patients with reversible obstructive airway…
Acute Migraine Treatments – What’s New?

Acute Migraine Treatments – What’s New?

Migraine is a neurological disorder with severe throbbing/pulsating headache generally associated with visual disturbances, nausea, vomiting, dizziness, and sensitivity to…
Gene Therapy – It’s Here, Are You Ready?

Gene Therapy – It’s Here, Are You Ready?

Thanks to advances in modern medicine, diseases caused by genetic disorders such as spinal muscular atrophy and retinal defects can…
Pandemic Response Update—Insights Into the Cycle

Pandemic Response Update—Insights Into the Cycle

As the COVID-19 Pandemic continues to sweep across the US, it seems there are new updates on the healthcare front…
Navigating the Complex World of Generics and Authorized Generics

Navigating the Complex World of Generics and Authorized Generics

Executive Summary Today, generics are widely available and more regulated, with improved quality compared to that of the not-so-distant past.…
What’s Really Going on with Drug Prices?

What’s Really Going on with Drug Prices?

Are prices up? Down? Staying the Same? The answer depends on who you listen to and when. In an atmosphere…
Like what you’re seeing? Get more Insights sent to you.